ArticleCellular and molecular life sciences : CMLS2026
mTORC1-signaling switches megalin function from endocytosis to cell cycle progression.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Megalin: from structure to function.Nature reviews. Nephrology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mechanistic target of rapamycin (mTOR) signaling pathway controls eukaryotic growth by regulating metabolism, translation, autophagy and cell cycle. Genetic deletion of renal mTORC1 led to a Fanconi-like syndrome with reduction of the renal cortex, tubular epithelial transport and perturbation of the endocytic machinery. Although the main scavenger receptor megalin remained unaltered, a new phosphorylation site at S4577 was found. The identification of the role of this mTORC1-induced phosphorylation on megalin was subject of our analysis. mTORC1-induced megalin phosphorylation reduced endocytosis rate with only minor distribution changes. It augmented the affinity of megalin to the adaptor protein ARH with consecutively increased proteolytic processing of megalin C-terminal domain and favored cell proliferation. During cell mitosis megalin is localized with ARH at the spindle pole. Compared to wildtype cells, megalin-deficient and ARH-deficient cells showed significantly less cell proliferation, and during cytokinesis significantly less ARH or megalin signals, respectively at the pole of intercellular bridges. mTORC1-induced megalin S4577 phopshorylation varies throughout the cell cycle with highest abundance in metaphase and telophase/cytokinesis. Both, lysosomal and non-lysosomal (external) nutrient supply influence cell proliferation to different extent. In conclusion, absence of the mTORC1-induced megalin S4577 phosphorylation favors cell growth and clathrin-mediated endocytosis whereas mTORC1-induced megalin phosphorylation at S4577 favors cell proliferation and increases the affinity to the adaptor protein ARH for proper cell division. Especially, during cytokinesis megalin and ARH ensure trafficking of membrane vesicles towards the pole of intercellular bridges most probably for the terminal abscission process.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.